X0508 4 2025-03-04 0001478320 Adaptive Biotechnologies Corp ADPT 0001780649 ROBINS CHAD M C/O ADAPTIVE BIOTECHNOLOGIES CORPORATION 1165 EASTLAKE AVENUE EAST SEATTLE WA 98109 1 1 0 0 CEO and Chairman 0 Common Stock 2025-03-04 4 A 0 355000 0 A 2931701 D Common Stock 2025-03-05 4 S 0 81206 6.98 D 2850495 D Common Stock 2025-03-05 4 S 0 36145 6.99 D 2814350 D Common Stock 2025-03-05 4 A 0 247117 0 A 3061467 D Common Stock 2025-03-06 4 S 0 102218 7.64 D 2959249 D This transaction represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. Each performance share unit represents a contingent right to receive one share of the issuer's common stock. The performance share units were granted on March 4, 2022, with respect to the three-year period ending on March 4, 2025. The issuer certified the achievement of the performance goals on March 5, 2025. The performance share units vested on March 5, 2025. This transaction represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of performance share units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. /s/ Chad M Robins by Kyle Piskel, Attorney-in-Fact 2025-03-06